Average Co-Inventor Count = 5.15
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Praecis Pharmaceuticals, Inc. (9 from 43 patents)
2. Provid Pharmaceuticals Inc. (4 from 6 patents)
3. University of California (1 from 15,458 patents)
4. National Institutes of Health, a Component of the US Dept. of Health & Human Services (1 from 3,435 patents)
5. Sequenom, Inc. (1 from 186 patents)
14 patents:
1. 8765802 - Kinase inhibitors, compositions thereof, and methods of use therewith
2. 8598312 - Inhibitors of antigen presentation by MHC class II molecules
3. 8222215 - Methods for the use of inhibitors of antigen presentation by MHC class II molecules
4. 7439231 - Inhibitors of antigen presentation by MHC class II molecules and methods of use thereof
5. 7432342 - Kinase anchor protein muteins, peptides thereof and related documents
6. 7405194 - Therapeutic agents and methods of use thereof for the treatment of melanoma
7. 7348307 - Methionine aminopeptidase-2 inhibitors and methods of use thereof
8. 7268111 - Therapeutic agents and methods of use thereof for the modulation of angiogenesis
9. 7157420 - Therapeutic agents and methods of use thereof for the modulation of angiogenesis
10. 7105482 - Methionine aminopeptidase-2 inhibitors and methods of use thereof
11. 7084108 - Therapeutic agents and methods of use thereof for the modulation of angiogenesis
12. 7037890 - Therapeutic agents and methods of use thereof for the modulation of angiogenesis
13. 6919307 - Therapeutic agents and methods of use thereof for the modulation of angiogenesis
14. 6548477 - Therapeutic agents and methods of use thereof for the modulation of angiogenesis